Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CardioVasc
Menlo Park, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
CardioVasc was a medical technology company focused on the development and commercialization of innovative devices for cardiovascular and peripheral vascular surgery. The company's primary product line included specialized systems designed to facilitate minimally invasive bypass procedures and improve surgical outcomes in patients with vascular disease. CardioVasc's technology aimed to simplify complex vascular connections, reducing the time and invasiveness of traditional surgical methods. The company was acquired by Edwards Lifesciences in 2000 to strengthen its portfolio in the cardiac surgery and peripheral vascular markets.
- Therapeutic areas
- Cardiovascular
- Modalities
- Device
- Industry
- Surgical Medical Devices
Beyond the preview
Go deeper on CardioVasc.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CardioVasc.